Literature DB >> 22001405

Self-assemble gene delivery system for molecular targeting using nucleic acid aptamer.

Tomoaki Kurosaki1, Norihide Higuchi, Shigeru Kawakami, Yuriko Higuchi, Tadahiro Nakamura, Takashi Kitahara, Mitsuru Hashida, Hitoshi Sasaki.   

Abstract

We have developed a novel vector constructed with pDNA, polyethylenimine (PEI), and mucin 1 (MUC1) aptamer for tumor-targeted gene delivery. The MUC1 aptamer and non-specific aptamer were employed to coat the pDNA/PEI complexes electrostatically and stable nanoparticles were formed. The addition of a non-specific aptamer to the pDNA/PEI complex decreased gene expression in the human lung cancer cell line, A549 cells expressing MUC1 regularly. At the same time, the pDNA/PEI/MUC1 aptamer complex showed higher gene expression than pDNA/PEI/non-specific aptamer complex. Furthermore, the pDNA/PEI/MUC1 aptamer complex showed markedly high gene expression in tumor-bearing mice; thus, pDNA/PEI/MUC1 aptamer complexes are useful as a tumor-targeted gene delivery system with high transfection efficiency.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001405     DOI: 10.1016/j.gene.2011.09.021

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

Review 1.  Nanoparticle ligand presentation for targeting solid tumors.

Authors:  Jason T Duskey; Kevin G Rice
Journal:  AAPS PharmSciTech       Date:  2014-06-14       Impact factor: 3.246

2.  Direct validation of aptamers as powerful tools to image solid tumor.

Authors:  Olivier Martínez; Elisabeth Bellard; Muriel Golzio; Saad Mechiche-Alami; Marie-Pierre Rols; Justin Teissié; Vincent Ecochard; Laurent Paquereau
Journal:  Nucleic Acid Ther       Date:  2014-02-03       Impact factor: 5.486

3.  Aptamer-functionalized nanoparticles for medical applications: challenges and opportunities.

Authors:  Zeyu Xiao; Omid C Farokhzad
Journal:  ACS Nano       Date:  2012-05-10       Impact factor: 15.881

Review 4.  Aptamers: A promising chemical antibody for cancer therapy.

Authors:  Gang Zhou; George Wilson; Lionel Hebbard; Wei Duan; Christopher Liddle; Jacob George; Liang Qiao
Journal:  Oncotarget       Date:  2016-03-22

Review 5.  Current and Prospective Protein Biomarkers of Lung Cancer.

Authors:  Tatiana N Zamay; Galina S Zamay; Olga S Kolovskaya; Ruslan A Zukov; Marina M Petrova; Ana Gargaun; Maxim V Berezovski; Anna S Kichkailo
Journal:  Cancers (Basel)       Date:  2017-11-13       Impact factor: 6.639

Review 6.  Aptamer Hybrid Nanocomplexes as Targeting Components for Antibiotic/Gene Delivery Systems and Diagnostics: A Review.

Authors:  Navid Rabiee; Sepideh Ahmadi; Zeynab Arab; Mojtaba Bagherzadeh; Moein Safarkhani; Behzad Nasseri; Mohammad Rabiee; Mohammadreza Tahriri; Thomas J Webster; Lobat Tayebi
Journal:  Int J Nanomedicine       Date:  2020-06-17

Review 7.  Aptamers Chemistry: Chemical Modifications and Conjugation Strategies.

Authors:  Fadwa Odeh; Hamdi Nsairat; Walhan Alshaer; Mohammad A Ismail; Ezaldeen Esawi; Baraa Qaqish; Abeer Al Bawab; Said I Ismail
Journal:  Molecules       Date:  2019-12-18       Impact factor: 4.411

Review 8.  Advances in Oligonucleotide Aptamers for NSCLC Targeting.

Authors:  Deborah Rotoli; Laura Santana-Viera; Maria L Ibba; Carla L Esposito; Silvia Catuogno
Journal:  Int J Mol Sci       Date:  2020-08-23       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.